Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Simpson-Yap S, De Brouwer E, Kalincik T, Rijke N, Hillert JA, Walton C, Edan G, Moreau Y, Spelman T, Geys L, Parciak T, Gautrais C, Lazovski N, Pirmani A, Ardeshirdavanai A, Forsberg L, Glaser A, McBurney R, Schmidt H, Bergmann AB, Braune S, Stahmann A, Middleton R, Salter A, Fox RJ, van der Walt A, Butzkueven H, Alroughani R, Ozakbas S, Rojas JI, van der Mei I, Nag N, Ivanov R, Sciascia do Olival G, Dias AE, Magyari M, Brum D, Mendes MF, Alonso RN, Nicholas RS, Bauer J, Chertcoff AS, Zabalza A, Arrambide G, Fidao A, Comi G, Peeters L. Simpson-Yap S, et al. Among authors: zabalza a. Neurology. 2021 Nov 9;97(19):e1870-e1885. doi: 10.1212/WNL.0000000000012753. Epub 2021 Oct 5. Neurology. 2021. PMID: 34610987 Free PMC article.
Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies.
Carvajal R, Rodríguez-Acevedo B, García-Vasco L, Zabalza A, Ariño H, Bollo L, Cabello-Clotet N, Castilló J, Cobo-Calvo Á, Comabella M, Falcó-Roget A, Galán I, García-Sarreón A, Gómez-Estévez I, Granados G, La Puma D, Mato Chain G, Midaglia L, Nieto-García A, Otero-Romero S, Pappolla A, Rodriguez M, Sansano I, Río J, Tagliani P, Tur C, Vidal-Jordana Á, Vilaseca A, Villar A, Sastre-Garriga J, Oreja-Guevara C, Tintoré M, Montalban X, Arrambide G. Carvajal R, et al. Among authors: zabalza a. Mult Scler. 2024 Dec;30(14):1788-1801. doi: 10.1177/13524585241297038. Epub 2024 Nov 9. Mult Scler. 2024. PMID: 39520297
MiRNA-based therapeutic potential in multiple sclerosis.
Zabalza A, Pappolla A, Comabella M, Montalban X, Malhotra S. Zabalza A, et al. Front Immunol. 2024 Aug 29;15:1441733. doi: 10.3389/fimmu.2024.1441733. eCollection 2024. Front Immunol. 2024. PMID: 39267760 Free PMC article. Review.
Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial.
Guerra-Farfan E, Borges FK, Bhandari M, Garcia-Sanchez Y, Nuñez JH, Mestre-Torres J, Tomas-Hernandez J, Teixidor-Serra J, Balaguer-Castro M, Castillon P, Dealbert A, De Caso Rodriguez J, Aguado HJ, Guerado E, Popova E, Tonelli AC, Balasubramanian K, Vincent J, Harvey V, Kocaqi E, Slobogean G, Devereaux PJ; Hip Attack-1 Investigators. Guerra-Farfan E, et al. Injury. 2024 Nov;55(11):111827. doi: 10.1016/j.injury.2024.111827. Epub 2024 Aug 20. Injury. 2024. PMID: 39217648 Clinical Trial.
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.
Carvajal R, Zabalza A, Carbonell-Mirabent P, Martínez-Gómez X, Esperalba J, Pappolla A, Rando A, Cobo-Calvo A, Tur C, Rodriguez M, Río J, Comabella M, Castilló J, Rodrigo-Pendás JÁ, Braga N, Mongay-Ochoa N, Guío-Sánchez C, Vidal-Jordana Á, Arrambide G, Rodríguez-Acevedo B, Midaglia L, Borras-Bermejo B, Galán I, Sastre-Garriga J, Montalban X, Otero-Romero S, Tintoré M. Carvajal R, et al. Among authors: zabalza a. JAMA Netw Open. 2024 Apr 1;7(4):e246345. doi: 10.1001/jamanetworkopen.2024.6345. JAMA Netw Open. 2024. PMID: 38607624 Free PMC article.
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
Pappolla A, Auger C, Sao-Aviles A, Tur C, Rodriguez-Barranco M, Cobo-Calvo Á, Mongay-Ochoa N, Rodríguez-Acevedo B, Zabalza A, Midaglia L, Carbonell-Mirabent P, Carvajal R, Castilló-Justribó J, Braga N, Bollo L, Vidal-Jordana A, Arrambide G, Nos C, Salerno A, Galán I, Comabella M, Sastre-Garriga J, Tintoré M, Rovira A, Montalban X, Río J. Pappolla A, et al. Among authors: zabalza a. Mult Scler. 2024 Jun;30(7):820-832. doi: 10.1177/13524585241240653. Epub 2024 Mar 29. Mult Scler. 2024. PMID: 38551315
Role of glutathione S-transferases in the mode of action of herbicides that inhibit amino acid synthesis in Amaranthus palmeri.
Eceiza MV, Jimenez-Martinez C, Gil-Monreal M, Barco-Antoñanzas M, Font-Farre M, Huybrechts M, van der Hoorn RL, Cuypers A, Royuela M, Zabalza A. Eceiza MV, et al. Among authors: zabalza a. Plant Physiol Biochem. 2024 Mar;208:108506. doi: 10.1016/j.plaphy.2024.108506. Epub 2024 Mar 5. Plant Physiol Biochem. 2024. PMID: 38461753 Free article.
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Bollo L, Arrambide G, Cobo-Calvo A, Alvarez JV, Alberich M, Cabello S, Castilló J, Galan I, Midaglia LS, Acevedo BR, Zabalza A, Pappolla A, Mongay Ochoa N, Tintore M, Rio J, Comabella M, Tur C, Auger C, Sastre-Garriga J, Rovira A, Montalban X, Pareto D, Vidal-Jordana A. Bollo L, et al. Among authors: zabalza a. Neurology. 2024 Apr 9;102(7):e209156. doi: 10.1212/WNL.0000000000209156. Epub 2024 Mar 6. Neurology. 2024. PMID: 38447105
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.
Dalla Costa G, Nos C, Zabalza A, Buron M, Magyari M, Sellebjerg F, Guerrero AI, Roselli L, La Porta ML, Martinis M, Bailon R, Kontaxis S, Laporta E, Garcia E, Pokorny FB, Schuller BW, Folarin A, Stewart C, Leocani L, Vairavan S, Cummins N, Dobson R, Hotopf M, Narayan V, Montalban X, Sorensen PS, Comi G. Dalla Costa G, et al. Among authors: zabalza a. Mult Scler. 2024 Jan;30(1):103-112. doi: 10.1177/13524585231214362. Epub 2023 Dec 12. Mult Scler. 2024. PMID: 38084497
107 results